New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development

Uložené v:

Podrobná bibliografia
Vydané v:	Antimicrobial agents and chemotherapy Ročník 53; číslo 3; s. 849 - 862
Hlavní autori:	van den Boogaard, Jossy, Kibiki, Gibson S, Kisanga, Elton R, Boeree, Martin J, Aarnoutse, Rob E
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.03.2009
Predmet:	Animals Antitubercular Agents - pharmacokinetics Antitubercular Agents - pharmacology Clinical Trials as Topic Dose-Response Relationship, Drug Drug Design Drug Evaluation, Preclinical Drug Resistance, Bacterial Fluoroquinolones - adverse effects Humans Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - genetics Rifamycins - pharmacokinetics Rifamycins - pharmacology Tuberculosis - drug therapy Tuberculosis - microbiology Tuberculosis - therapy
ISSN:	1098-6596
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Popis
Bibliografia:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
ISSN:	1098-6596
DOI:	10.1128/AAC.00749-08